SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Clinical trial NCT03433183 · COMPLETED
Trial details
- NCT number
- NCT03433183
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2022-06-22
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.